Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Genmark Diagnostics (GNMK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 381,647
  • Shares Outstanding, K 55,955
  • Annual Sales, $ 52,520 K
  • Annual Income, $ -61,850 K
  • 36-Month Beta 1.49
  • Price/Sales 5.60
  • Price/Cash Flow N/A
  • Price/Book 9.03

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.15
  • Number of Estimates 2
  • High Estimate -0.15
  • Low Estimate -0.15
  • Prior Year -0.21
  • Growth Rate Est. (year over year) +28.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.69 +19.86%
on 01/23/19
6.90 -1.16%
on 02/21/19
+0.81 (+13.48%)
since 01/18/19
3-Month
3.58 +90.50%
on 12/21/18
6.90 -1.16%
on 02/21/19
+1.81 (+36.13%)
since 11/21/18
52-Week
3.58 +90.50%
on 12/21/18
8.81 -22.59%
on 08/30/18
+2.36 (+52.91%)
since 02/21/18

Most Recent Stories

More News
GenMark Diagnostics (GNMK) Reports Q4 Loss, Tops Revenue Estimates

GenMark Diagnostics (GNMK) delivered earnings and revenue surprises of -31.25% and 0.83%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

GNMK : 6.82 (+1.34%)
GenMark Diagnostics Reports Fourth Quarter and Full Year 2018 Results

GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the fourth quarter and year ended December...

GNMK : 6.82 (+1.34%)
GenMark Diagnostics Announces Expansion of Executive Leadership Team

GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced the expansion of its executive leadership team. Effective immediately,...

GNMK : 6.82 (+1.34%)
GenMark Diagnostics to Participate in Upcoming Investor Conferences

GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in two upcoming investor...

MHMNF : 54.5000 (unch)
GNMK : 6.82 (+1.34%)
30.0% Return Seen to Date on SmarTrend Genmark Diagnost Call (GNMK)

SmarTrend identified an Uptrend for Genmark Diagnost (NASDAQ:GNMK) on January 3rd, 2019 at $4.82. In approximately 2 months, Genmark Diagnost has returned 30.01% as of today's recent price of $6.26.

GNMK : 6.82 (+1.34%)
GenMark Diagnostics Schedules Fourth Quarter and Full Year 2018 Financial Results Conference Call for February 21, 2019

GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its fourth quarter earnings results after market close on Thursday, February 21, 2019. Management will hold a conference...

GNMK : 6.82 (+1.34%)
Shares of GNMK Up 29.6% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Genmark Diagnost (NASDAQ:GNMK) on January 3rd, 2019 at $4.82. In approximately 3 weeks, Genmark Diagnost has returned 29.60% as of today's recent price of $6.24.

GNMK : 6.82 (+1.34%)
GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2018

GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided preliminary operational and financial results for the year ended...

GNMK : 6.82 (+1.34%)
GenMark Diagnostics Receives FDA 510(k) Market Clearance for its ePlex Blood Culture Identification Fungal Pathogen Panel

Two of Three ePlex Blood Culture Identification Panels Now Cleared for Marketing in the U.S.

GNMK : 6.82 (+1.34%)
GenMark Diagnostics to Present at the J.P. Morgan Healthcare Conference

GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the Company plans to participate in the J.P. Morgan Healthcare...

GNMK : 6.82 (+1.34%)
JPM : 105.47 (-0.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade GNMK with:

Business Summary

GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. The eSensor' XT-8 system is the second generation in GenMark Dx's eSensor' platform, utilizing electrochemical detection technology to detect nucleic...

See More

Key Turning Points

2nd Resistance Point 7.05
1st Resistance Point 6.93
Last Price 6.82
1st Support Level 6.67
2nd Support Level 6.53

See More

52-Week High 8.81
Last Price 6.82
Fibonacci 61.8% 6.81
Fibonacci 50% 6.20
Fibonacci 38.2% 5.58
52-Week Low 3.58

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar